Locations
England, UK · Oxford, UK · Oxfordshire, UK
industry
Health · Hospital & Health Care
Size
51-200 employees
Stage
Series B
founded in
2017
Ultromics is the leader in artificial intelligence for echocardiography, enabling earlier detection and risk stratification of heart failure for better outcomes, lower costs, and improved patient care. All providers, regardless of their care setting, can now make precise, accurate, and timely diagnoses of heart failure with Ultromics’ AI technology. The cloud-based platform, EchoGo, offers a simple, secure, and seamless way to augment your existing technology and workflow with fully automated, advanced echo analysis including critical advanced measures recommended by guidelines. The technology is FDA-cleared and CE-marked, and trusted by world-renowned organizations such as Mayo Clinic and the NHS England.
Something looks off?